COVID-19 Impact on Bronchodilator Market, Global Research Reports 2020-2021

Code: QYRE-Auto-11J2914

Report

May 2020

Pages:95

QYResearch

Description

Table of Content

Tables & Figures

FEATURED COMPANIES

Kissei Pharmaceutical

Mitsubishi Tanabe Pharma

Sanofi

Theron Pharmaceuticals

This report covers market size and forecasts of Bronchodilator, including the following market information:

Global Bronchodilator Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Doses)

Global Bronchodilator Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Doses)

Global Bronchodilator Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Doses)

Global Bronchodilator Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Doses)

Key market players

Major competitors identified in this market include GlaxoSmithKline, Roche, AstraZeneca, Boehringer Ingelheim, Amgen, Kissei Pharmaceutical, Mitsubishi Tanabe Pharma, Sanofi, Theron Pharmaceuticals, Array BioPharma, Kyowa Hakko Kirin, Verona Pharma, Nycomed Pharma, etc.

Based on the Region:

Asia-Pacific (China, Japan, South Korea, India and ASEAN)

North America (US and Canada)

Europe (Germany, France, UK and Italy)

Rest of World (Latin America, Middle East & Africa)

Based on the Type:

Short-acting Bronchodilator

Long-acting Bronchodilator

Based on the Application:

Asthma

Chronic Obstructive Pulmonary Disease

Others

FEATURED COMPANIES

Kissei Pharmaceutical

Mitsubishi Tanabe Pharma

Sanofi

Theron Pharmaceuticals

1.1 Research Scope

1.2 Market Segmentation

1.3 Research Objectives

1.4 Research Methodology

1.4.1 Research Process

1.4.2 Data Triangulation

1.4.3 Research Approach

1.4.4 Base Year

1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

1.5.2 Covid-19 Impact: Commodity Prices Indices

1.5.3 Covid-19 Impact: Global Major Government Policy

1.6 The Covid-19 Impact on Bronchodilator Industry

1.7 COVID-19 Impact: Bronchodilator Market Trends

2 Global Bronchodilator Quarterly Market Size Analysis

2.1 Bronchodilator Business Impact Assessment - COVID-19

2.1.1 Global Bronchodilator Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.1.2 Global Bronchodilator Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.2 Global Bronchodilator Quarterly Market Size 2020-2021

2.3 COVID-19-Driven Market Dynamics and Factor Analysis

2.3.1 Drivers

2.3.2 Restraints

2.3.3 Opportunities

2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

3.1 Global Bronchodilator Quarterly Market Size by Manufacturers, 2019 VS 2020

3.2 Global Bronchodilator Factory Price by Manufacturers

3.3 Location of Key Manufacturers Bronchodilator Manufacturing Factories and Area Served

3.4 Date of Key Manufacturers Enter into Bronchodilator Market

3.5 Key Manufacturers Bronchodilator Product Offered

3.6 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Bronchodilator Segments, By Type

4.1 Introduction

1.4.1 Short-acting Bronchodilator

1.4.2 Long-acting Bronchodilator

4.2 By Type, Global Bronchodilator Market Size, 2019-2021

4.2.1 By Type, Global Bronchodilator Market Size by Type, 2020-2021

4.2.2 By Type, Global Bronchodilator Price, 2020-2021

5 Impact of Covid-19 on Bronchodilator Segments, By Application

5.1 Overview

5.5.1 Asthma

5.5.2 Chronic Obstructive Pulmonary Disease

5.5.3 Others

5.2 By Application, Global Bronchodilator Market Size, 2019-2021

5.2.1 By Application, Global Bronchodilator Market Size by Application, 2019-2021

5.2.2 By Application, Global Bronchodilator Price, 2020-2021

6 Geographic Analysis

6.1 Introduction

6.2 North America

6.2.1 Macroeconomic Indicators of US

6.2.2 US

6.2.3 Canada

6.3 Europe

6.3.1 Macroeconomic Indicators of Europe

6.3.2 Germany

6.3.3 France

6.3.4 UK

6.3.5 Italy

6.4 Asia-Pacific

6.4.1 Macroeconomic Indicators of Asia-Pacific

6.4.2 China

6.4.3 Japan

6.4.4 South Korea

6.4.5 India

6.4.6 ASEAN

6.5 Rest of World

6.5.1 Latin America

6.5.2 Middle East and Africa

7 Company Profiles

7.1 GlaxoSmithKline

7.1.1 GlaxoSmithKline Business Overview

7.1.2 GlaxoSmithKline Bronchodilator Quarterly Production and Revenue, 2020

7.1.3 GlaxoSmithKline Bronchodilator Product Introduction

7.1.4 GlaxoSmithKline Response to COVID-19 and Related Developments

7.2 Roche

7.2.1 Roche Business Overview

7.2.2 Roche Bronchodilator Quarterly Production and Revenue, 2020

7.2.3 Roche Bronchodilator Product Introduction

7.2.4 Roche Response to COVID-19 and Related Developments

7.3 AstraZeneca

7.3.1 AstraZeneca Business Overview

7.3.2 AstraZeneca Bronchodilator Quarterly Production and Revenue, 2020

7.3.3 AstraZeneca Bronchodilator Product Introduction

7.3.4 AstraZeneca Response to COVID-19 and Related Developments

7.4 Boehringer Ingelheim

7.4.1 Boehringer Ingelheim Business Overview

7.4.2 Boehringer Ingelheim Bronchodilator Quarterly Production and Revenue, 2020

7.4.3 Boehringer Ingelheim Bronchodilator Product Introduction

7.4.4 Boehringer Ingelheim Response to COVID-19 and Related Developments

7.5 Amgen

7.5.1 Amgen Business Overview

7.5.2 Amgen Bronchodilator Quarterly Production and Revenue, 2020

7.5.3 Amgen Bronchodilator Product Introduction

7.5.4 Amgen Response to COVID-19 and Related Developments

7.6 Kissei Pharmaceutical

7.6.1 Kissei Pharmaceutical Business Overview

7.6.2 Kissei Pharmaceutical Bronchodilator Quarterly Production and Revenue, 2020

7.6.3 Kissei Pharmaceutical Bronchodilator Product Introduction

7.6.4 Kissei Pharmaceutical Response to COVID-19 and Related Developments

7.7 Mitsubishi Tanabe Pharma

7.7.1 Mitsubishi Tanabe Pharma Business Overview

7.7.2 Mitsubishi Tanabe Pharma Bronchodilator Quarterly Production and Revenue, 2020

7.7.3 Mitsubishi Tanabe Pharma Bronchodilator Product Introduction

7.7.4 Mitsubishi Tanabe Pharma Response to COVID-19 and Related Developments

7.8 Sanofi

7.8.1 Sanofi Business Overview

7.8.2 Sanofi Bronchodilator Quarterly Production and Revenue, 2020

7.8.3 Sanofi Bronchodilator Product Introduction

7.8.4 Sanofi Response to COVID-19 and Related Developments

7.9 Theron Pharmaceuticals

7.9.1 Theron Pharmaceuticals Business Overview

7.9.2 Theron Pharmaceuticals Bronchodilator Quarterly Production and Revenue, 2020

7.9.3 Theron Pharmaceuticals Bronchodilator Product Introduction

7.9.4 Theron Pharmaceuticals Response to COVID-19 and Related Developments

7.10 Array BioPharma

7.10.1 Array BioPharma Business Overview

7.10.2 Array BioPharma Bronchodilator Quarterly Production and Revenue, 2020

7.10.3 Array BioPharma Bronchodilator Product Introduction

7.10.4 Array BioPharma Response to COVID-19 and Related Developments

7.11 Kyowa Hakko Kirin

7.11.1 Kyowa Hakko Kirin Business Overview

7.11.2 Kyowa Hakko Kirin Bronchodilator Quarterly Production and Revenue, 2020

7.11.3 Kyowa Hakko Kirin Bronchodilator Product Introduction

7.11.4 Kyowa Hakko Kirin Response to COVID-19 and Related Developments

7.12 Verona Pharma

7.12.1 Verona Pharma Business Overview

7.12.2 Verona Pharma Bronchodilator Quarterly Production and Revenue, 2020

7.12.3 Verona Pharma Bronchodilator Product Introduction

7.12.4 Verona Pharma Response to COVID-19 and Related Developments

7.13 Nycomed Pharma

7.13.1 Nycomed Pharma Business Overview

7.13.2 Nycomed Pharma Bronchodilator Quarterly Production and Revenue, 2020

7.13.3 Nycomed Pharma Bronchodilator Product Introduction

7.13.4 Nycomed Pharma Response to COVID-19 and Related Developments

8 Supply Chain and Sales Channels Analysis

8.1 Bronchodilator Supply Chain Analysis

8.1.1 Bronchodilator Supply Chain Analysis

8.1.2 Covid-19 Impact on Bronchodilator Supply Chain

8.2 Distribution Channels Analysis

8.2.1 Bronchodilator Distribution Channels

8.2.2 Covid-19 Impact on Bronchodilator Distribution Channels

8.2.3 Bronchodilator Distributors

8.3 Bronchodilator Customers

9 Key Findings

10 Appendix

10.1 About Us

10.2 Disclaimer

FEATURED COMPANIES

Kissei Pharmaceutical

Mitsubishi Tanabe Pharma

Sanofi

Theron Pharmaceuticals

List of Tables

Table 1. Overview of the World Economic Outlook Projections

Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 7. Covid-19 Impact: Global Major Government Policy

Table 8. The Covid-19 Impact on Bronchodilator Assessment

Table 9. COVID-19 Impact: Bronchodilator Market Trends

Table 10. COVID-19 Impact Global Bronchodilator Market Size

Table 11. Global Bronchodilator Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Doses)

Table 12. Global Bronchodilator Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Dose)

Table 13. Global Bronchodilator Quarterly Market Size, 2020 (US$ Million) & (K Doses)

Table 14. Global Bronchodilator Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)

Table 15. Global Bronchodilator Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Doses)

Table 16. Global Bronchodilator Market Growth Drivers

Table 17. Global Bronchodilator Market Restraints

Table 18. Global Bronchodilator Market Opportunities

Table 19. Global Bronchodilator Market Challenges

Table 20. Key Manufacturers Bronchodilator Quarterly Revenue, 2019 VS 2020 (US$ Million)

Table 21. Top Manufacturers, Bronchodilator Market Size, 2019 (K Doses) & (US$ Million)

Table 22. Bronchodilator Factory Price by Manufacturers 2020 (USD/Dose)

Table 23. Location of Key Manufacturers Bronchodilator Manufacturing Plants

Table 24. Key Manufacturers Bronchodilator Market Served

Table 25. Date of Key Manufacturers Enter into Bronchodilator Market

Table 26. Key Manufacturers Bronchodilator Product Type

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Bronchodilator Market Size by Type, 2020, (US$ Million)

Table 29. Global Bronchodilator Market Size by Type, 2020 (K Doses)

Table 30. Global Bronchodilator Price: by Type, 2020-2021 (USD/Dose)

Table 31. Global Bronchodilator Market Size by Application: 2020-2021 (US$ Million)

Table 32. Global Bronchodilator Market Size by Application, 2020-2021 (K Doses)

Table 33. Global Bronchodilator Price: by Application, 2020-2021 (USD/Dose)

Table 34. Global Bronchodilator Market Size by Region, 2019-2021 (US$ Million)

Table 35. Global Bronchodilator Market Size by Region, 2019-2021 (K Doses)

Table 36. By Country, North America Bronchodilator Market Size, 2019-2021 (US$ Million)

Table 37. By Country, North America Bronchodilator Market Size, 2019-2021 (K Doses)

Table 38. US Bronchodilator Market Size, 2019-2021 (US$ Million) & (K Doses)

Table 39. Canada Bronchodilator Market Size, 2019-2021 (US$ Million) & (K Doses)

Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)

Table 41. By Country, Europe Bronchodilator Market Size, 2019-2021 (US$ Million)

Table 42. By Country, Europe Bronchodilator Market Size, 2019-2021 (K Doses)

Table 43. Germany Bronchodilator Market Size, 2019-2021 (US$ Million) & (K Doses)

Table 44. France Bronchodilator Market Size, 2019-2021 (US$ Million) & (K Doses)

Table 45. UK Bronchodilator Market Size, 2019-2021 (US$ Million) & (K Doses)

Table 46. Italy Bronchodilator Market Size, 2019-2021 (US$ Million) & (K Doses)

Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)

Table 48. By Region, Asia-Pacific Bronchodilator Market Size, 2019-2021 (US$ Million)

Table 49. By Region, Asia-Pacific Bronchodilator Market Size, 2019-2021 (K Doses)

Table 50. China Bronchodilator Market Size, 2019-2021 (US$ Million) & (K Doses)

Table 51. Japan Bronchodilator Market Size, 2019-2021 (US$ Million) & (K Doses)

Table 52. South Korea Bronchodilator Market Size, 2019-2021 (US$ Million) & (K Doses)

Table 53. India Bronchodilator Market Size, 2019-2021 (US$ Million) & (K Doses)

Table 54. ASEAN Bronchodilator Market Size, 2019-2021 (US$ Million) & (K Doses)

Table 55. Latin America Bronchodilator Market Size, 2019-2021 (US$ Million) & (K Doses)

Table 56. Middle East and Africa Bronchodilator Market Size, 2019-2021 (US$ Million) & (K Doses)

Table 57. GlaxoSmithKline Business Overview

Table 58. GlaxoSmithKline Bronchodilator Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 59. GlaxoSmithKline Bronchodilator Product

Table 60. GlaxoSmithKline Response to COVID-19 and Related Developments

Table 61. Roche Business Overview

Table 62. Roche Bronchodilator Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 63. Roche Bronchodilator Product

Table 64. Roche Response to COVID-19 and Related Developments

Table 65. AstraZeneca Business Overview

Table 66. AstraZeneca Bronchodilator Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 67. AstraZeneca Bronchodilator Product

Table 68. AstraZeneca Response to COVID-19 and Related Developments

Table 69. Boehringer Ingelheim Business Overview

Table 70. Boehringer Ingelheim Bronchodilator Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 71. Boehringer Ingelheim Bronchodilator Product

Table 72. Boehringer Ingelheim Response to COVID-19 and Related Developments

Table 73. Amgen Business Overview

Table 74. Amgen Bronchodilator Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 75. Amgen Bronchodilator Product

Table 76. Amgen Response to COVID-19 and Related Developments

Table 77. Kissei Pharmaceutical Business Overview

Table 78. Kissei Pharmaceutical Bronchodilator Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 79. Kissei Pharmaceutical Bronchodilator Product

Table 80. Kissei Pharmaceutical Response to COVID-19 and Related Developments

Table 81. Mitsubishi Tanabe Pharma Business Overview

Table 82. Mitsubishi Tanabe Pharma Bronchodilator Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 83. Mitsubishi Tanabe Pharma Bronchodilator Product

Table 84. Mitsubishi Tanabe Pharma Response to COVID-19 and Related Developments

Table 85. Sanofi Business Overview

Table 86. Sanofi Bronchodilator Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 87. Sanofi Bronchodilator Product

Table 88. Sanofi Response to COVID-19 and Related Developments

Table 89. Theron Pharmaceuticals Business Overview

Table 90. Theron Pharmaceuticals Bronchodilator Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 91. Theron Pharmaceuticals Bronchodilator Product

Table 92. Theron Pharmaceuticals Response to COVID-19 and Related Developments

Table 93. Array BioPharma Business Overview

Table 94. Array BioPharma Bronchodilator Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 95. Array BioPharma Bronchodilator Product

Table 96. Array BioPharma Response to COVID-19 and Related Developments

Table 97. Kyowa Hakko Kirin Business Overview

Table 98. Kyowa Hakko Kirin Bronchodilator Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 99. Kyowa Hakko Kirin Bronchodilator Product

Table 100. Kyowa Hakko Kirin Response to COVID-19 and Related Developments

Table 101. Verona Pharma Business Overview

Table 102. Verona Pharma Bronchodilator Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 103. Verona Pharma Bronchodilator Product

Table 104. Verona Pharma Response to COVID-19 and Related Developments

Table 105. Nycomed Pharma Business Overview

Table 106. Nycomed Pharma Bronchodilator Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 107. Nycomed Pharma Bronchodilator Product

Table 108. Nycomed Pharma Response to COVID-19 and Related Developments

Table 109. Bronchodilator Distributors List

Table 110. Bronchodilator Customers List

Table 111. Covid-19 Impact on Bronchodilator Customers

List of Figures

Figure 1. Bronchodilator Product Picture

Figure 2. Bronchodilator Market Segmentation

Figure 3. Research Objectives

Figure 4. Research Process

Figure 5. Data Triangulation

Figure 6. Research Approach

Figure 7. Commodity Prices-Metals Price Indices

Figure 8. Commodity Prices- Precious Metal Price Indices

Figure 9. Commodity Prices- Agricultural Raw Material Price Indices

Figure 10. Commodity Prices- Food and Beverage Price Indices

Figure 11. Commodity Prices- Fertilizer Price Indices

Figure 12. Commodity Prices- Energy Price Indices

Figure 13. G20+: Economic Policy Responses to COVID-19

Figure 14. Global Bronchodilator Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)

Figure 15. Global Bronchodilator Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)

Figure 16. Global Bronchodilator Market Size, Quarterly Growth, 2020-2021 (%)

Figure 17. Global Bronchodilator Market Size, Market Share by Type, 2019 VS 2020 (%)

Figure 18. Global Bronchodilator Market Size, Market Share by Application, 2019 VS 2020 (%)

Figure 19. Global Bronchodilator Market Size Market Share by Region, 2019 VS 2020 (%)

Figure 20. United States Composite PMI and GDP

Figure 21. Eurozone Composite PMI and GDP

Figure 22. Eurozone Core v. Periphery PMI Output Indices

Figure 23. Core v. Periphery PMI Employment Indices

Figure 24. UK Composite PMI and GDP

Figure 25. Caixin China Composite Output Index

Figure 26. Caixin China General Services Business Activity Index

Figure 27. Japan Composite Output Index

Figure 28. South Korea Manufacturing PMI

Figure 29. India Composite Output Index

Figure 30. ASEAN Manufacturing PMI

Figure 31. By Region, Asia-Pacific Bronchodilator Market Size Market Share, 2019-2021

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3250

This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)

$4875

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$6500

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

COVID-19 Impact on Bronchodilator Market, Global Research Reports 2020-2021

Published Date: May 2020

Report Code: QYRE-Auto-11J2914

COVID-19 Impact on Bronchodilator Market, Global Research Reports 2020-2021

FEATURED COMPANIES

FEATURED COMPANIES

FEATURED COMPANIES

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-4O8609

Wed Apr 17 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-25I8231

Wed Apr 17 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-2M4266

Wed Apr 17 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-38E8328

Wed Apr 17 00:00:00 UTC 2024

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions